-
2
-
-
84894707183
-
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
-
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology 2014;59:318-327.
-
(2014)
Hepatology
, vol.59
, pp. 318-327
-
-
Smith, D.B.1
Bukh, J.2
Kuiken, C.3
Muerhoff, A.S.4
Rice, C.M.5
Stapleton, J.T.6
Simmonds, P.7
-
3
-
-
7444256169
-
Genetic diversity and evolution of hepatitis C virus-15 years on
-
Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 2004;85:3173-3188.
-
(2004)
J Gen Virol
, vol.85
, pp. 3173-3188
-
-
Simmonds, P.1
-
4
-
-
0031017973
-
The origin of hepatitis C virus genotypes
-
Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol 1997;78:321-328.
-
(1997)
J Gen Virol
, vol.78
, pp. 321-328
-
-
Smith, D.B.1
Pathirana, S.2
Davidson, F.3
Lawlor, E.4
Power, J.5
Yap, P.L.6
Simmonds, P.7
-
5
-
-
78751544998
-
Genetic recombination of the hepatitis C virus: clinical implications
-
Morel V, Fournier C, Francois C, Brochot E, Helle F, Duverlie G, Castelain S. Genetic recombination of the hepatitis C virus: clinical implications. J Viral Hepat 2011;18:77-83.
-
(2011)
J Viral Hepat
, vol.18
, pp. 77-83
-
-
Morel, V.1
Fournier, C.2
Francois, C.3
Brochot, E.4
Helle, F.5
Duverlie, G.6
Castelain, S.7
-
6
-
-
84901624146
-
Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus
-
Galli A, Bukh J. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus. Trends Microbiol 2014;22:354-364.
-
(2014)
Trends Microbiol
, vol.22
, pp. 354-364
-
-
Galli, A.1
Bukh, J.2
-
7
-
-
0036196640
-
A natural intergenotypic recombinant of hepatitis C virus identified in St
-
Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002;76:4034-4043.
-
(2002)
Petersburg. J Virol
, vol.76
, pp. 4034-4043
-
-
Kalinina, O.1
Norder, H.2
Mukomolov, S.3
Magnius, L.O.4
-
8
-
-
84863421649
-
Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b
-
Raghwani J, Thomas XV, Koekkoek SM, Schinkel J, Molenkamp R, van de Laar TJ, et al. Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. J Virol 2012;86:2212-2220.
-
(2012)
J Virol
, vol.86
, pp. 2212-2220
-
-
Raghwani, J.1
Thomas, X.V.2
Koekkoek, S.M.3
Schinkel, J.4
Molenkamp, R.5
van de Laar, T.J.6
-
9
-
-
54949116213
-
Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b
-
Kurbanov F, Tanaka Y, Chub E, Maruyama I, Azlarova A, Kamitsukasa H, et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis 2008;198:1448-1456.
-
(2008)
J Infect Dis
, vol.198
, pp. 1448-1456
-
-
Kurbanov, F.1
Tanaka, Y.2
Chub, E.3
Maruyama, I.4
Azlarova, A.5
Kamitsukasa, H.6
-
10
-
-
34247111934
-
New natural intergenotypic (2/5) recombinant of hepatitis C virus
-
Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 2007;81:4357-4362.
-
(2007)
J Virol
, vol.81
, pp. 4357-4362
-
-
Legrand-Abravanel, F.1
Claudinon, J.2
Nicot, F.3
Dubois, M.4
Chapuy-Regaud, S.5
Sandres-Saune, K.6
-
11
-
-
33749553986
-
A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines
-
Kageyama S, Agdamag DM, Alesna ET, Leano PS, Heredia AM, Abellanosa-Tac-An IP, et al. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006;78:1423-1428.
-
(2006)
J Med Virol
, vol.78
, pp. 1423-1428
-
-
Kageyama, S.1
Agdamag, D.M.2
Alesna, E.T.3
Leano, P.S.4
Heredia, A.M.5
Abellanosa-Tac-An, I.P.6
-
12
-
-
80053442905
-
Naturally occurring genotype 2b/1a hepatitis C virus in the United States
-
Bhattacharya D, Accola MA, Ansari IH, Striker R, Rehrauer WM. Naturally occurring genotype 2b/1a hepatitis C virus in the United States. Virol J 2011;8:458.
-
(2011)
Virol J
, vol.8
, pp. 458
-
-
Bhattacharya, D.1
Accola, M.A.2
Ansari, I.H.3
Striker, R.4
Rehrauer, W.M.5
-
13
-
-
33746214690
-
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus
-
Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006;80:7569-7577.
-
(2006)
J Virol
, vol.80
, pp. 7569-7577
-
-
Noppornpanth, S.1
Lien, T.X.2
Poovorawan, Y.3
Smits, S.L.4
Osterhaus, A.D.5
Haagmans, B.L.6
-
14
-
-
73449101124
-
Optimizing the treatment of chronic viral hepatitis C
-
Francois C, Castelain S, Duverlie G, Capron D, Nguyen-Khac E. Optimizing the treatment of chronic viral hepatitis C. Expert Rev Gastroenterol Hepatol 2009;3:607-613.
-
(2009)
Expert Rev Gastroenterol Hepatol
, vol.3
, pp. 607-613
-
-
Francois, C.1
Castelain, S.2
Duverlie, G.3
Capron, D.4
Nguyen-Khac, E.5
-
15
-
-
84856304724
-
Treatment failure with new hepatitis C drugs
-
Soriano V, Vispo E, Poveda E, Labarga P, Barreiro P. Treatment failure with new hepatitis C drugs. Expert Opin Pharmacother 2012;13:313-323.
-
(2012)
Expert Opin Pharmacother
, vol.13
, pp. 313-323
-
-
Soriano, V.1
Vispo, E.2
Poveda, E.3
Labarga, P.4
Barreiro, P.5
-
16
-
-
79953733509
-
Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191)
-
Imhof I, Simmonds P. Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191). Hepatology 2011;53:1090-1099.
-
(2011)
Hepatology
, vol.53
, pp. 1090-1099
-
-
Imhof, I.1
Simmonds, P.2
-
17
-
-
84871814966
-
Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C
-
Gane EJ, Stedman CA, Hyland RH, Ding X, Svarovskaia E, Symonds WT, et al. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. N Engl J Med 2013;368:34-44.
-
(2013)
N Engl J Med
, vol.368
, pp. 34-44
-
-
Gane, E.J.1
Stedman, C.A.2
Hyland, R.H.3
Ding, X.4
Svarovskaia, E.5
Symonds, W.T.6
-
18
-
-
84878976866
-
Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naïve patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
-
Kowdley KV, Lawitz E, Crespo I, Hassanein T, Davis MN, DeMicco M, et al. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naïve patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial. Lancet 2013;381:2100-2107.
-
(2013)
Lancet
, vol.381
, pp. 2100-2107
-
-
Kowdley, K.V.1
Lawitz, E.2
Crespo, I.3
Hassanein, T.4
Davis, M.N.5
DeMicco, M.6
-
19
-
-
84880964894
-
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial
-
Rodriguez-Torres M, Lawitz E, Kowdley KV, Nelson DR, Dejesus E, McHutchison JG, et al. Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial. J Hepatol 2013;58:663-668.
-
(2013)
J Hepatol
, vol.58
, pp. 663-668
-
-
Rodriguez-Torres, M.1
Lawitz, E.2
Kowdley, K.V.3
Nelson, D.R.4
Dejesus, E.5
McHutchison, J.G.6
-
20
-
-
84876740954
-
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naïve patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
-
Lawitz E, Lalezari JP, Hassanein T, Kowdley KV, Poordad FF, Sheikh AM, et al. Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naïve patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial. Lancet Infect Dis 2013;13:401-408.
-
(2013)
Lancet Infect Dis
, vol.13
, pp. 401-408
-
-
Lawitz, E.1
Lalezari, J.P.2
Hassanein, T.3
Kowdley, K.V.4
Poordad, F.F.5
Sheikh, A.M.6
-
21
-
-
84877730954
-
Sofosbuvir for previously untreated chronic hepatitis C infection
-
Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 2013;368:1878-1887.
-
(2013)
N Engl J Med
, vol.368
, pp. 1878-1887
-
-
Lawitz, E.1
Mangia, A.2
Wyles, D.3
Rodriguez-Torres, M.4
Hassanein, T.5
Gordon, S.C.6
-
22
-
-
84900992889
-
Sofosbuvir and ribavirin in HCV genotypes 2 and 3
-
Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, et al. Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 2014;370:1993-2001.
-
(2014)
N Engl J Med
, vol.370
, pp. 1993-2001
-
-
Zeuzem, S.1
Dusheiko, G.M.2
Salupere, R.3
Mangia, A.4
Flisiak, R.5
Hyland, R.H.6
-
23
-
-
84900339263
-
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
-
Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med 2014;370:1889-1898.
-
(2014)
N Engl J Med
, vol.370
, pp. 1889-1898
-
-
Afdhal, N.1
Zeuzem, S.2
Kwo, P.3
Chojkier, M.4
Gitlin, N.5
Puoti, M.6
-
24
-
-
84898669547
-
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
-
Afdhal N, Reddy KR, Nelson DR, Lawitz E, Gordon SC, Schiff E, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 2014;370:1483-1493.
-
(2014)
N Engl J Med
, vol.370
, pp. 1483-1493
-
-
Afdhal, N.1
Reddy, K.R.2
Nelson, D.R.3
Lawitz, E.4
Gordon, S.C.5
Schiff, E.6
-
25
-
-
84877739274
-
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
-
Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med 2013;368:1867-1877.
-
(2013)
N Engl J Med
, vol.368
, pp. 1867-1877
-
-
Jacobson, I.M.1
Gordon, S.C.2
Kowdley, K.V.3
Yoshida, E.M.4
Rodriguez-Torres, M.5
Sulkowski, M.S.6
-
26
-
-
25844523297
-
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
-
Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.
-
(2005)
Hepatology
, vol.42
, pp. 962-973
-
-
Simmonds, P.1
Bukh, J.2
Combet, C.3
Deleage, G.4
Enomoto, N.5
Feinstone, S.6
-
27
-
-
34247254413
-
Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay
-
Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Lefrere JJ, et al. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 2007;45:1140-1145.
-
(2007)
J Clin Microbiol
, vol.45
, pp. 1140-1145
-
-
Bouchardeau, F.1
Cantaloube, J.F.2
Chevaliez, S.3
Portal, C.4
Razer, A.5
Lefrere, J.J.6
-
28
-
-
25444523728
-
Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications
-
Kurn N, Chen P, Heath JD, Kopf-Sill A, Stephens KM, Wang S. Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. Clin Chem 2005;51:1973-1981.
-
(2005)
Clin Chem
, vol.51
, pp. 1973-1981
-
-
Kurn, N.1
Chen, P.2
Heath, J.D.3
Kopf-Sill, A.4
Stephens, K.M.5
Wang, S.6
-
29
-
-
84866113768
-
De novo assembly of highly diverse viral populations
-
Yang X, Charlebois P, Gnerre S, Coole MG, Lennon NJ, Levin JZ, et al. De novo assembly of highly diverse viral populations. BMC Genomics 2012;13:475.
-
(2012)
BMC Genomics
, vol.13
, pp. 475
-
-
Yang, X.1
Charlebois, P.2
Gnerre, S.3
Coole, M.G.4
Lennon, N.J.5
Levin, J.Z.6
-
30
-
-
0032889281
-
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
-
Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
-
(1999)
J Virol
, vol.73
, pp. 152-160
-
-
Lole, K.S.1
Bollinger, R.C.2
Paranjape, R.S.3
Gadkari, D.4
Kulkarni, S.S.5
Novak, N.G.6
-
31
-
-
0027968068
-
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
-
Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
-
(1994)
Nucleic Acids Res
, vol.22
, pp. 4673-4680
-
-
Thompson, J.D.1
Higgins, D.G.2
Gibson, T.J.3
-
33
-
-
33745256005
-
Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative
-
Anisimova M, Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst Biol 2006;55:539-552.
-
(2006)
Syst Biol
, vol.55
, pp. 539-552
-
-
Anisimova, M.1
Gascuel, O.2
-
34
-
-
77950806408
-
New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0
-
Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010;59:307-321.
-
(2010)
Syst Biol
, vol.59
, pp. 307-321
-
-
Guindon, S.1
Dufayard, J.F.2
Lefort, V.3
Anisimova, M.4
Hordijk, W.5
Gascuel, O.6
-
35
-
-
77949434590
-
Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report
-
Morel V, Descamps V, Francois C, Fournier C, Brochot E, Capron D, et al. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report. J Clin Virol 2010;47:382-386.
-
(2010)
J Clin Virol
, vol.47
, pp. 382-386
-
-
Morel, V.1
Descamps, V.2
Francois, C.3
Fournier, C.4
Brochot, E.5
Capron, D.6
-
36
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
Smith, C.4
Marinos, G.5
Goncales, F.L.6
-
37
-
-
84897084133
-
Once-daily sofosbuvir plus ribavirin given for 12 or 24 weeks in treatment-naïve patients with HCV infection: the QUANTUM Study
-
Lalezari JP, Nelson DR, Hyland RH, Lin M, Rossi SJ, Symonds WT, et al. Once-daily sofosbuvir plus ribavirin given for 12 or 24 weeks in treatment-naïve patients with HCV infection: the QUANTUM Study. J Hepatol 2013;56(Suppl 1):S88-S100.
-
(2013)
J Hepatol
, vol.56
, pp. S88-S100
-
-
Lalezari, J.P.1
Nelson, D.R.2
Hyland, R.H.3
Lin, M.4
Rossi, S.J.5
Symonds, W.T.6
-
38
-
-
84892619580
-
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
-
Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, et al. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014;370:211-221.
-
(2014)
N Engl J Med
, vol.370
, pp. 211-221
-
-
Sulkowski, M.S.1
Gardiner, D.F.2
Rodriguez-Torres, M.3
Reddy, K.R.4
Hassanein, T.5
Jacobson, I.6
-
39
-
-
33846160587
-
Recombinant hepatitis C virus in experimentally infected chimpanzees
-
Gao F, Nainan OV, Khudyakov Y, Li J, Hong Y, Gonzales AC, et al. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol 2007;88:143-147.
-
(2007)
J Gen Virol
, vol.88
, pp. 143-147
-
-
Gao, F.1
Nainan, O.V.2
Khudyakov, Y.3
Li, J.4
Hong, Y.5
Gonzales, A.C.6
-
40
-
-
79960399455
-
Hepatitis C virus RNA recombination in cell culture
-
Reiter J, Perez-Vilaro G, Scheller N, Mina LB, Diez J, Meyerhans A. Hepatitis C virus RNA recombination in cell culture. J Hepatol 2011;55:777-783.
-
(2011)
J Hepatol
, vol.55
, pp. 777-783
-
-
Reiter, J.1
Perez-Vilaro, G.2
Scheller, N.3
Mina, L.B.4
Diez, J.5
Meyerhans, A.6
-
41
-
-
84875984443
-
Productive homologous and non-homologous recombination of hepatitis C virus in cell culture
-
Scheel TK, Galli A, Li YP, Mikkelsen LS, Gottwein JM, Bukh J. Productive homologous and non-homologous recombination of hepatitis C virus in cell culture. PLoS Pathog 2013;9:e1003228.
-
(2013)
PLoS Pathog
, vol.9
, pp. e1003228
-
-
Scheel, T.K.1
Galli, A.2
Li, Y.P.3
Mikkelsen, L.S.4
Gottwein, J.M.5
Bukh, J.6
-
42
-
-
0026602984
-
RNA recombination in animal and plant viruses
-
Lai MM. RNA recombination in animal and plant viruses. Microbiol Rev 1992;56:61-79.
-
(1992)
Microbiol Rev
, vol.56
, pp. 61-79
-
-
Lai, M.M.1
|